Although iron deficiency anemia and heavy menstrual bleeding are also implicated in menopausal thrombosis risk, suppression of anticoagulant proteins such as PS may further exacerbate hypercoagulability in these women. Here, PRB2 is linked to Iron deficiency anemia.